Tracy Weslosky
-
eResearch’s Chris Thompson with James Howard-Tripp on StageZero’s COVID-19 testing revenue
In a recent InvestorIntel interview, Chris Thompson speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
James Howard-Tripp on StageZero’s Q1 Results, Aristotle as part of the AVRT Program and the Rexall Partnership for COVID-19 Saliva Tests
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX:…
-
FutureVault’s John Shackleton on the importance of information security in the financial service industry
In a recent InvestorIntel interview, Tracy Weslosky spoke with John Shackleton, CEO of FutureVault, about FutureVault’s secure, cloud-based…
-
Sixth Wave Innovations Dr Jon Gluckman on the colorimetric detection of SARS-CoV-2
In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
Thomas Smeenk on Hemostemix’s autologous stem cell therapy technology and why some call it ‘the fountain of youth’
In a recent InvestorIntel interview, Tracy Weslosky spoke with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…
-
StageZero Life Sciences James Howard-Tripp on the recent LOI to Acquire Health Clinics Limited
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
David Kerbel on launching Rritual’s premium brand of functional superfoods in Rite Aid stores throughout the USA
In a recent InvestorIntel interview, Tracy Weslosky spoke with David Kerbel, CEO and Director of Rritual Superfoods Inc.…
